CharlesJLinkJr.MDFACP

Clinical Trials

• Vaccine Study for Surgically Resected Pancreatic Cancer Start of enrollment: 2007 Dec 01

  Completed

  Phase 2

• Low Dose Vaccine Study for Surgically Resected Pancreatic Cancer Start of enrollment: 2008 Jan 01

  Terminated

  Phase 2

• IDO Inhibitor Study for Relapsed or Refractory Solid Tumors Start of enrollment: 2008 Aug 01

  Terminated

  Phase 1

• Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate Cancer Start of enrollment: 2012 Oct 01

  Completed

  Phase 2

• Study of IDO Inhibitor in Combination With Checkpoint Inhibitors for Adult Patients With Metastatic Melanoma Start of enrollment: 2014 Jul 01

  Completed

  Phase 1, Phase 2

• Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer Start of enrollment: 2014 Aug 01

  Completed

  Phase 1, Phase 2

• Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors Start of enrollment: 2015 Oct 01

  Completed

  Phase 1

• A Study of Indoximod in Combination With (7+3) Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2016 Jul 01

  Completed

  Phase 1

• A Study of Indoximod or Placebo Plus Pembrolizumab or Nivolumab for Subjects With Unresectable or Metastatic Melanoma Start of enrollment: 2017 Dec 08

  Terminated

  Phase 2

• Oral Bioavailability,and Food Effect Study and Single Ascending Dose PK Study in Healthy Male Volunteers Start of enrollment: 2017 Nov 21

  Completed

  Phase 1

• Single Ascending Dose PK, Oral Bioavailability and Food Effect Study in Healthy Male Volunteers Start of enrollment: 2018 Mar 05

  Completed

  Early Phase 1

• Join now to see all